76 episodes
- Investigational drug clinical trials depend on far more than protocol design, patient recruitment, and data collection. A critical part of trial execution is the pharmacy team responsible for supporting the study.
These specialized pharmacy teams are often known as Investigational Drug Services, or IDS. They help ensure that the right investigational drug, at the right dose, is administered to the right participant, at the right time, and in compliance with the clinical trial protocol.
In this episode of the Clinical Trial Podcast, Dr. Kevin Zinchuk joins the conversation to explain the role of Investigational Drug Services in clinical trials.
Kevin is the Pharmacy Manager for Investigational Drug Services at Brigham and Women's Hospital, where he works closely with researchers across the public and private sectors to conceptualize, develop, and operationalize interventional clinical trials.
He also serves as the Program Director for Brigham and Women's Hospital's PGY2 Investigational Drugs and Research Pharmacy Residency. Kevin has published and presented on investigational drug and compounding practice and holds the Certified Clinical Research Professional credential through SOCRA.
In this conversation, Kevin shares how Investigational Drug Services support clinical trial execution, what sponsors and study teams should understand about pharmacy operations, and how stronger collaboration with IDS can improve the conduct of clinical trials. How Statisticians Really Think About Endpoints, Power, and FDA Review with Roseann White
31/07/2026 | 1h 23 mins.Statistics influence almost every major decision in a clinical trial.
In this episode, Roseann White, a retired biostatistician with more than 30 years of experience, joins the Clinical Trial Podcast to make biostatistics practical for clinical research professionals.
Roseann explains what statistical significance really means, why clinical meaning matters, how to think about superiority and non-inferiority, and why sensitivity and specificity can confuse even experienced teams.
We also discuss endpoint selection, statistical analysis plans, financial constraints, FDA disagreements, and the questions non-statisticians should ask earlier in the trial design process.
This is a practical conversation for anyone involved in designing, conducting, analyzing, or interpreting clinical trials.How Clinical Research Hiring Decisions Are Actually Made with Giovanni Lauricella
30/04/2026 | 1h 7 mins.Why do qualified candidates apply to role after role in clinical research and never hear back?
In this episode of the Clinical Trial Podcast, we unpack what's really happening behind the scenes in the hiring process.
Getting hired isn't just about your technical skills. It's about how hiring managers assess risk, how recruiters decide who to champion, and who actually gets attention versus who gets ignored.
Kunal Sampat is joined by Giovanni Lauricella, Co-Founder and CEO of Lifeblood, an executive search firm specializing in MedTech. With over 15 years of experience placing board members, C-suite leaders, and cross-functional talent globally, Giovanni brings a unique perspective from inside the hiring process.
In this episode, you'll learn:
Why strong candidates get filtered out before interviews
What hiring managers are actually looking for
How recruiters decide who to advocate for
What it really takes to break into and advance in clinical research
If you've ever felt stuck in your job search or wondered why the process feels like a black box, this conversation will give you a clearer understanding of how hiring decisions are actually made.- What separates strong clinical research from misleading conclusions?
Often, it comes down to study design.
In this episode of the Clinical Trial Podcast, Kunal Sampat sits down with Dr. Thomas Newman, Professor of Epidemiology and Biostatistics at UCSF and co-author of Designing Clinical Research, to break down how observational studies actually work.
While randomized controlled trials are often considered the gold standard, observational studies are essential in many real-world settings. But they come with challenges including bias, confounding, and misinterpretation that can lead to flawed conclusions if not handled correctly.
Dr. Newman shares a practical framework to help you design better studies, interpret results more critically, and build a stronger foundation in clinical research.
In this episode, you'll learn:
When observational studies are more appropriate than randomized trials
A practical framework for designing observational research
Key threats to validity: bias, confounding, and chance
How to interpret associations vs. causal effects
Strategies for dealing with confounders in analysis
How to approach statistics with more clarity and confidence
About the guest:
Dr. Thomas Newman, MD, MPH, is a Professor of Epidemiology and Biostatistics at the University of California, San Francisco. His work focuses on applying epidemiologic methods to important clinical problems in child health, including neonatal jaundice, infections in newborns, and cholesterol screening.
He is widely recognized for his contributions to clinical research education and is co-author of Designing Clinical Research and Evidence-Based Diagnosis.
Why this episode matters:
If you want to grow in clinical research, you need more than surface-level knowledge - you need to understand how studies are designed and where they can go wrong.
This episode helps you think like a clinical researcher. - Bringing a high-risk cardiovascular device from concept to patient care requires more than innovation - it requires carefully designed clinical trials, strong operational execution, and close collaboration with regulators and physician investigators.
In this episode of the Clinical Trial Podcast, Kunal Sampat speaks with Nicole Haratani about how cardiovascular device clinical trials are actually designed and run. Nicole is Vice President of Clinical Affairs at Supira Medical and has spent more than two decades working in medical device clinical research, particularly in cardiovascular technologies.
Nicole shares insights from her experience leading clinical and regulatory programs across feasibility and pivotal trials, and explains the operational realities behind Class III device studies.
In this episode, we discuss:
How cardiovascular devices move from concept to clinical trials
Designing feasibility and pivotal trials for Class III devices
How inclusion and exclusion criteria are developed
Challenges in patient recruitment for cardiovascular studies
Collaborating with key opinion leaders and investigators
Working with the FDA during the PMA process
Career advice for professionals interested in medical device clinical research
If you're interested in cardiovascular device development, clinical trial operations, or building a career in medical device research, this episode provides a practical look at how complex device trials are executed.
More Business podcasts
Trending Business podcasts
About Clinical Trial Podcast | Conversations with Clinical Research Experts
Clinical research and clinical trial management form the backbone of drug and device approvals worldwide. Learn from the leading industry experts to build and advance your clinical research career.
You'll hear from sponsors, clinical research organizations, and clinical trial sites around the globe. This show is for all current and aspiring clinical research professionals including clinical research associates (CRA), clinical operations managers, study managers, biostatisticians, medical doctors, safety monitors, clinical scientists and other healthcare professionals.
To learn more, visit https://clinicaltrialpodcast.com/
Podcast websiteListen to Clinical Trial Podcast | Conversations with Clinical Research Experts, The Other Hand and many other podcasts from around the world with the radio.net app

Get the free radio.net app
- Stations and podcasts to bookmark
- Stream via Wi-Fi or Bluetooth
- Supports Carplay & Android Auto
- Many other app features







































